1. Home
  2. LDWY vs SBFM Comparison

LDWY vs SBFM Comparison

Compare LDWY & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LDWY
  • SBFM
  • Stock Information
  • Founded
  • LDWY 1990
  • SBFM 2006
  • Country
  • LDWY United States
  • SBFM Canada
  • Employees
  • LDWY N/A
  • SBFM N/A
  • Industry
  • LDWY Advertising
  • SBFM Biotechnology: Pharmaceutical Preparations
  • Sector
  • LDWY Consumer Discretionary
  • SBFM Health Care
  • Exchange
  • LDWY Nasdaq
  • SBFM Nasdaq
  • Market Cap
  • LDWY 9.2M
  • SBFM 6.3M
  • IPO Year
  • LDWY 1991
  • SBFM N/A
  • Fundamental
  • Price
  • LDWY $4.43
  • SBFM $0.31
  • Analyst Decision
  • LDWY
  • SBFM Strong Buy
  • Analyst Count
  • LDWY 0
  • SBFM 1
  • Target Price
  • LDWY N/A
  • SBFM $260.00
  • AVG Volume (30 Days)
  • LDWY 2.4K
  • SBFM 1.5M
  • Earning Date
  • LDWY 08-08-2024
  • SBFM 08-08-2024
  • Dividend Yield
  • LDWY N/A
  • SBFM N/A
  • EPS Growth
  • LDWY N/A
  • SBFM N/A
  • EPS
  • LDWY N/A
  • SBFM N/A
  • Revenue
  • LDWY $14,244,000.00
  • SBFM $26,739,780.00
  • Revenue This Year
  • LDWY N/A
  • SBFM $87.97
  • Revenue Next Year
  • LDWY N/A
  • SBFM $125.23
  • P/E Ratio
  • LDWY N/A
  • SBFM N/A
  • Revenue Growth
  • LDWY 337.74
  • SBFM 193.30
  • 52 Week Low
  • LDWY $3.72
  • SBFM $0.28
  • 52 Week High
  • LDWY $8.15
  • SBFM $64.50
  • Technical
  • Relative Strength Index (RSI)
  • LDWY 41.51
  • SBFM 34.83
  • Support Level
  • LDWY $4.43
  • SBFM $0.29
  • Resistance Level
  • LDWY $4.62
  • SBFM $0.35
  • Average True Range (ATR)
  • LDWY 0.06
  • SBFM 0.03
  • MACD
  • LDWY 0.03
  • SBFM 0.03
  • Stochastic Oscillator
  • LDWY 8.57
  • SBFM 17.89

About LDWY Lendway Inc. (DE)

Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

Share on Social Networks: